Skip to main navigation Skip to search Skip to main content

Prevalence of group B Streptococcus colonization in pregnant women and serotype specific immunity among mother-newborns dyads in Ghana and Zimbabwe

  • Irene Apewe Adjei
  • , Zivai Mupambireyi
  • , Sarah A. White
  • , Edward Matsikire
  • , Alex Manu
  • , Nisha Dhar
  • , Louisa Iddrisu
  • , Elizabeth Mathai
  • , Sam Newton
  • , Luis Cuevas
  • , Oscar Agyei
  • , Andrew Carey
  • , Yeetey Akpe Enuameh
  • , Jones Opoku-Mensah
  • , Matthews Mathai
  • , Frances Cowan
  • , Kwaku Poku Asante
  • , Gaurav Kwatra
  • Kintampo Health Research Centre
  • Kwame Nkrumah University of Science and Technology
  • Centre for Sexual Health and HIV/AIDS Research
  • Liverpool School of Tropical Medicine
  • University of the Witwatersrand, Johannesburg
  • Cincinnati Children's Hospital Medical Center
  • University of Cincinnati
  • Christian Medical College, Vellore

Research output: Contribution to journalArticlepeer-review

Abstract

Background: Rectovaginal colonization with Streptococcus agalactiae (Group B Streptococcus; GBS) during pregnancy is a major risk factor for neonatal invasive GBS disease and adverse birth outcomes. We investigated the prevalence of maternal GBS colonization, serotype-specific immunoglobulin G (IgG) immunity in mother-newborn dyads, and GBS associated stillbirths in Ghana and Zimbabwe. Methods: A prospective cohort of 1238 pregnant women and their infants was enrolled (2018–2020). Recto-vaginal swabs collected at ≥36 weeks gestation or prior to delivery and chest aspirates from stillbirths were cultured for GBS. Isolates were serotyped using latex agglutination. Maternal and cord blood samples were analysed for GBS serotype-specific IgG using a multiplex bead-based immunoassay. Results: The prevalence of recto-vaginal GBS colonization was 15.6% (68/437) in Ghana and 15.2% (50/329) in Zimbabwe. GBS was detected in 33.3% (3/9) of stillbirths. Dominant colonizing serotypes were Ia (25%), III (32%), and V (27%). Maternal IgG concentrations were significantly higher in Ghana than in Zimbabwe for serotypes Ib (0.11 vs 0.02 μg/mL; p = 0.0001), II (0.24 vs 0.06 μg/mL; p = 0.0001), and IV (0.03 vs 0.006 μg/mL; p < 0.0001). Transplacental IgG transfer ratios ranged from 0.81 to 1.08; highest for serotype II and lowest for Ia. Newborns with IgG above the serological thresholds for risk reduction for serotype Ia and III were 25.6% (Ia) and 38.4% (III) in Ghana; and 34.1% (Ia) and 26.8% (III) in Zimbabwe. Conclusions: The predominant GBS serotypes distribution in Ghana and Zimbabwe aligns with global epidemiological patterns. Despite evidence of natural maternal IgG immunity and efficient transplacental transfer, most newborns lacked protective antibody levels against GBS. A maternal GBS vaccine targeting dominant serotypes may reduce the risk of GBS neonatal invasive disease and GBS-associated stillbirths.

Original languageEnglish
Article number128626
JournalVaccine
Volume82
DOIs
Publication statusPublished - 22 May 2026

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Colonization
  • Group BStreptococcus
  • Humoral immunity
  • Newborns
  • Pregnant women
  • Stillbirths

Fingerprint

Dive into the research topics of 'Prevalence of group B Streptococcus colonization in pregnant women and serotype specific immunity among mother-newborns dyads in Ghana and Zimbabwe'. Together they form a unique fingerprint.

Cite this